Blopress and Activated partial thromboplastin time prolonged - a phase IV clinical study of FDA data

Summary:

Activated partial thromboplastin time prolonged is reported as a side effect among people who take Blopress (candesartan cilexetil), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Votrient, and have Depression.

The phase IV clinical study analyzes which people have Activated partial thromboplastin time prolonged when taking Blopress. It is created by eHealthMe based on reports of 7,451 people who have side effects when taking Blopress from the FDA, and is updated regularly.

What is Blopress?

Blopress has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 7,479 Blopress users. Check the latest studies of Blopress.

What is Activated partial thromboplastin time prolonged?

Activated partial thromboplastin time prolonged is found to be associated with 761 drugs and 1,211 conditions by eHealthMe. Check the latest studies of Activated partial thromboplastin time prolonged.

On Jul, 27, 2026

7,451 people reported to have side effects when taking Blopress.
Among them, 11 people (0.15%) have Activated partial thromboplastin time prolonged.

Could Blopress cause Activated partial thromboplastin time prolonged?

Among these 11 people:

How long have people been on Blopress when they have Activated partial thromboplastin time prolonged? *

What is the gender of people who have Activated partial thromboplastin time prolonged when taking Blopress? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Activated partial thromboplastin time prolonged when taking Blopress? *

What are other drugs people take besides Blopress? *

Votrient: 3 people, 27.27%
Xarelto: 1 person, 9.09%
Samsca: 1 person, 9.09%
Rivaroxaban: 1 person, 9.09%
Pradaxa: 1 person, 9.09%

What are other side effects people have besides Activated partial thromboplastin time prolonged? *

Blood Urea Increased: 8 people, 72.73%
General Physical Health Deterioration (weak health status): 6 people, 54.55%
Peripheral Vascular Disorder: 5 people, 45.45%
Itching: 5 people, 45.45%
Liver Function Test Abnormal: 5 people, 45.45%
Muscle Swelling: 5 people, 45.45%
Diarrhea: 5 people, 45.45%
Cardiovascular Insufficiency (inadequate functioning of heart): 5 people, 45.45%
Haemoglobin Decreased: 5 people, 45.45%
Blood Creatinine Increased: 5 people, 45.45%

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 5 people, 45.45%
Depression: 5 people, 45.45%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 3 people, 27.27%
Insomnia (sleeplessness): 3 people, 27.27%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 27.27%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 27.27%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 27.27%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 9.09%
Diabetes: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Blopress and have Activated partial thromboplastin time prolonged?

- Check whether Activated partial thromboplastin time prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Blopress:

Blopress (7,479 reports)

Activated partial thromboplastin time prolonged treatments and more:

Activated partial thromboplastin time prolonged (8,799 reports)

How severe was Activated partial thromboplastin time prolonged and when was it recovered:

Activated partial thromboplastin time prolonged in Blopress

Expand to all the drugs that have ingredients of candesartan cilexetil:

Activated partial thromboplastin time prolonged and drugs with ingredients of candesartan cilexetil (118 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Blopress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (761 drugs)

Browse all the conditions that are associated with Activated partial thromboplastin time prolonged:

Activated partial thromboplastin time prolonged (1,211 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil (the active ingredients of Blopress) and Blopress (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.